"It's not about what they tell you, it's about what they don't."
~ Bob Fiddaman, Author, Blogger, Researcher, Recipient of two Human Rights awards
Researching drug company and regulatory malfeasance for over 16 years
Humanist, humorist
Thursday, April 09, 2020
"Your Drugs May Pose A Greater Risk Than Your Covid"
Fresh off the press. Such an important video. This interview is part of the #COVID19Chronicles.
Please share far and wide. We owe it to ourselves and our loved ones.
This video struck a chord with me as I posed the following question on Twitter last week, a question that we should, I feel, all be asking.
The video, below, is an interview between journalist, Frank Barat, and Dr David Healy.
Healy's words resonate and make you wonder if this is another reason why the coronavirus fatalities in the elderly are high. Maybe this is something scientists need to be looking into as it may give them insight as to why certain people get severe cases of the Covid19 virus compared to others.
Polypharmacy
Polypharmacy is the concurrent use of multiple medications by a patient. Polypharmacy is most common in the elderly, affecting about 40% of older adults living in their own homes. ... Definitions have ranged from two medications at a time to 18, or to more medications than clinically necessary.
"A lot of these drugs, from antidepressants to pain killers to all sorts of other drugs, may compromise our immune system to make us more vulnerable to catching Covid and the other thing they can do is they can compromise the body's ability to fight back if we get Covid making us more likely to get pneumonia. When you look at the people who seem to be dying it's older people and particularly people who are in residential homes who are on a whole lot of drugs, sometimes it seems just to keep them quiet rather than treat an illness." ~ Dr David Healy, psychiatrist, psychopharmacologist, scientist, and author
Subscribe to:
Post Comments (Atom)
Please contact me if you would like a guest post considered for publication on my blog.
No comments: